Related Experiment Video

Updated: Jul 5, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas

X Mao1, G Orchard

  • 1Skin Tumour Unit, St John's Institute of Dermatology, St Thomas' Hospital, King's College London, UK. mxmayo@yahoo.co.uk

The British Journal of Dermatology
|May 8, 2008
PubMed

Insights

This study reveals abnormal activator protein 1 (AP-1) expression in primary cutaneous B-cell lymphoma (PCBCL), with increased JUND, CCND1, and alphaPAK and decreased JUNB. These findings offer insights into PCBCL pathogenesis.

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Primary cutaneous B-cell lymphoma (PCBCL) encompasses several subtypes, including PCMZL, PCFCL, and PCLBCL-LT.
  • The activator protein 1 (AP-1) transcription factor family, including JUN and FOS proteins, plays a role in cellular processes.

Purpose of the Study:

  • To investigate the expression patterns of AP-1 transcription factors in various subtypes of PCBCL.
  • To identify potential correlations between AP-1 family members and PCBCL development.

Main Methods:

  • Immunohistochemistry was employed to analyze paraffin-embedded tissue sections from 24 PCBCL cases.
  • Antibodies targeting c-JUN, JUNB, JUND, c-FOS, RAF1, alphaPAK, CD30, and CCND1 were used.

Main Results:

  • JUND protein expression was notably high in PCFCL (86%), PCLBCL-LT (83%), and PCMZL (56%).
  • CCND1 expression was observed in PCLBCL-LT (67%), PCFCL (57%), and PCMZL (44%).
  • AlphaPAK expression was detected in PCLBCL-LT (50%), PCMZL (22%), and PCFCL (14%), while c-JUN, c-FOS, RAF1, JUNB, and CD30 showed minimal to no expression.

Conclusions:

  • Abnormal AP-1 protein expression, specifically upregulation of JUND, CCND1, and alphaPAK, and downregulation of JUNB, is associated with PCBCL.
  • These findings suggest a role for altered AP-1 signaling in the pathogenesis of primary cutaneous B-cell lymphomas.
Abstract

More Related Videos

CUBIC Protocol Visualizes Protein Expression at Single Cell Resolution in Whole Mount Skin Preparations08:09

CUBIC Protocol Visualizes Protein Expression at Single Cell Resolution in Whole Mount Skin Preparations

Published on: August 4, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...